SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-098928
Filing Date
2023-12-27
Accepted
2023-12-27 16:51:05
Documents
12
Period of Report
2023-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea190756-8ka1_onconetix.htm   iXBRL 8-K/A 79269
  Complete submission text file 0001213900-23-098928.txt   272037

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20231215.xsd EX-101.SCH 3015
3 XBRL LABEL FILE onco-20231215_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE onco-20231215_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea190756-8ka1_onconetix_htm.xml XML 4646
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41294 | Film No.: 231518528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)